The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment
The DOI matches its Crossref record; 334 of the 342 references it cites were found in a registry or an index.
Abstract
Pregnancy dramatically affects the hypothalamic-pituitary-adrenal axis leading to increased circulating cortisol and ACTH levels during gestation, reaching values in the range seen in Cushing's syndrome (CS). The cause(s) of increased ACTH may include placental synthesis and release of biologically active CRH and ACTH, pituitary desensitization to cortisol feedback, or enhanced pituitary responses to corticotropin-releasing factors. In this context, challenges in diagnosis and management of disorders of the hypothalamic-pituitary-adrenal axis in pregnancy are discussed. CS in pregnancy is uncommon and is associated with fetal morbidity and mortality. The diagnosis may be missed because of overlapping clinical and biochemical features in pregnancy. The proportion of patients with primary adrenal causes of CS is increased in pregnancy. CRH stimulation testing and inferior petrosal sinus sampling can identify patients with Cushing's disease. Surgery is a safe option for treatment in the second trimester; otherwise medical therapy may be used. Women with known adrenal insufficiency that is appropriately treated can expect to have uneventful pregnancies. Whereas a fetal/placental source of cortisol may mitigate crisis during gestation, unrecognized adrenal insufficiency may lead to maternal or fetal demise either during gestation or in the puerperium. Appropriate treatment and management of labor are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure to DDAVP during pregnancy is safe (254), and DDAVP is generally considered safe for the newborn in lactating mothers (252).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [252]
In the citing paper
“During pregnancy, serum sodium and osmolarity are reduced due to a decreased threshold for ADH release and thirst mechanism (252).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [252]
Citations
Cites
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667 · cited 1×
“Although the majority of cases of primary AI affect women ( 92%) (223), the exact prevalence of AI occurring in association with pregnancy is unknown.”
BackgroundDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 5×
“As a result, the recommended diagnostic ACTH thresholds for adrenal CS in the general population are not valid in pregnancy and may lead to missed diagnoses (187).”
BackgroundMethodInfluentialSelf-citationObstetrics: Normal and Problem Pregnancies
(2017) · Elsevier eBooks · doi:10.1016/c2013-0-00408-2 · Cited by 1,176
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006 · cited 1×
“In one large series of hypopituitarism in the United Kingdom, 77% had been treated with surgery and 35% with pituitary radiotherapy (257).”
BackgroundA placental clock controlling the length of human pregnancy
McLean, M., Bisits, A., Davies, J., Woods, R., Lowry, P., & Smith, R. (1995) · Nature Medicine · doi:10.1038/nm0595-460 · Cited by 908 · cited 1×
“Maternal CRH acts as a biological clock that determines the length of gestation (55, 71), and premature or accelerated activation of the placental CRH system may be associated with earlier onset of labor and delivery (72).”
BackgroundOldfield, E. H., Doppman, J. L., Nieman, L. K., Chrousos, G. P., Miller, D. L., Katz, D. A., Cutler, G. B., & Loriaux, D. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251301 · Cited by 866 · cited 1×
“The central-to-peripheral ACTH gradient in patients with CD is not found in other causes of CS, providing a very high diagnostic accuracy in the differential diagnosis of ACTHdependent CS in the nonpregnant population (194).”
BackgroundSelf-citationOwens, P. C., Smith, R., Brinsmead, M. W., Hall, C., Rowley, M., Hurt, D., Lovelock, M., Chan, E.-C., Cubis, J., & Lewin, T. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90603-5 · Cited by 847 · cited 2×
“(147) observed normal responses to dexamethasone by the fifth postpartum week.”
BackgroundBetterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758 · cited 2×
“The presentation and causes of AI have been reviewed extensively (226, 227).”
BackgroundOelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Autoimmune Polyendocrine Syndromes
Eisenbarth, G. S., & Gottlieb, P. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030158 · Cited by 672
Hall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627 · cited 1×
“Evidence of a size criterion for pituitary incidentaloma stems from nonpregnant series (199).”
BackgroundMaternal and Fetal Hypothalamic‐Pituitary‐Adrenal Axes During Pregnancy and Postpartum
MASTORAKOS, G., & ILIAS, I. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.016 · Cited by 621 · cited 1×
“Locally produced embryonic and endometrial CRH impedes rejection during implantation by inducing apoptosis in activated leukocytes carrying Fas ligand, thereby protecting the fetus from the maternal immune system (54, 70).”
BackgroundPhillips, D. I. W., Barker, D. J. P., Fall, C. H. D., Seckl, J. R., Whorwood, C. B., Wood, P. J., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4634 · Cited by 596
Repeated antenatal corticosteroids: Size at birth and subsequent development
French, N. P., Hagan, R., Evans, S. F., Godfrey, M., & Newnham, J. P. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70160-2 · Cited by 558 · cited 1×
“The adverse effects of exogenous steroids and their contribution to fetal growth retardation, suppression of the fetal HPA axis and effects on neurological functioning, have previously been reviewed extensively in both animal models and in humans (241-245).”
BackgroundDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · cited 1×
“Stable isotope studies indicate a normal adult cortisol secretion rate of 4–8 mg/m(2) d, and present replacement regimens for the nonpregnant population may lead to overreplacement in a proportion of cases (317).”
BackgroundEndocrine mechanisms of intrauterine programming
Fowden, A. L., & Forhead, A. J. (2004) · Reproduction · doi:10.1530/rep.1.00033 · Cited by 471 · cited 1×
“The capacity of placental 11 -HSD 2 is sufficient to ensure that fetal cortisol levels are much lower than maternal levels (19).”
BackgroundDICKSTEIN, G., SHECHNER, C., NICHOLSON, W. E., ROSNER, I., SHEN-ORR, Z., ADAWI, F., & LAHAV, M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-773 · Cited by 457 · cited 1×
“There has been controversy as to whether the the LCT test offers additional sensitivity for detection of secondary AI (284, 292, 294, 295).”
BackgroundClinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442 · cited 2×
“An ACTH level above 100 pg/ml (22 pmol/liter) is generally consistent with primary AI, even in late pregnancy (281).”
BackgroundGlucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta.
Robinson, B. G., Emanuel, R. L., Frim, D. M., & Majzoub, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5244 · Cited by 440 · cited 3×
“(61) suggested that the rise in CRH preceding parturition could result from stimulation by elevated fetal glucocorticoids.”
BackgroundPost‐partum necrosis of the anterior pituitary
Sheehan, H. L. (1937) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700450118 · Cited by 400
Plasma Corticotropin-Releasing Hormone Concentrations During Pregnancy and Parturition*
CAMPBELL, E. A., LINTON, E. A., WOLFE, C. D. A., SCRAGGS, P. R., JONES, M. T., & LOWRY, P. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1054 · Cited by 387 · cited 4×
“CRH levels are significantly lower (20-fold) in umbilical cord plasma than in the maternal circulation and are close to the nonpregnant reference range (45).”
BackgroundInfluentialTranssphenoidal Microsurgery for Cushing Disease: A Report of 216 Cases
Mampalam, T. J., Tyrrell, J. B., & Wilson, C. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-6-487 · Cited by 386
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Diagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy
Carr, B. R., Parker, C. R., Madden, J. D., MacDonald, P. C., & Porter, J. C. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90318-5 · Cited by 370 · cited 23×
“plasma cortisol concentrations increase severalfold with the onset of labor and delivery (3, 45, 143).”
BackgroundMethodResultInfluentialPotter, E., Behan, D. P., Fischer, W. H., Linton, E. A., Lowry, P. J., & Vale, W. W. (1991) · Nature · doi:10.1038/349423a0 · Cited by 358 · cited 1×
“Systemic maternal effects of elevated CRH in pregnancy are thought to be limited due to binding of free bioactive CRH to CRH-BP, a 322-amino acid glycoprotein (63).”
BackgroundTen, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2909 · Cited by 350
Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy
wilson, M., Morganti, A. A., Zervoudakis, I., Letcher, R. L., Romney, B. M., Von Oeyon, P., Papera, S., Sealey, J. E., & Laragh, J. H. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90178-3 · Cited by 345 · cited 18×
“While plasma aldosterone levels and plasma renin activity are elevated in normal pregnancy, there are no data on these values in patients with AI (87), and cut-off points for AI in pregnancy have not been established.”
BackgroundInfluentialCushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
Lindsay, J. R., Jonklaas, J., Oldfield, E. H., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2361 · Cited by 343 · cited 10×
“The bars adjacent to the right axis are summary data derived from a recent series (173) to denote the range of serum cortisol observed in CS in pregnancy ( , median and range; n 52); ACTH values for CD (Œ, median and range; n 18) and adrenal CS (‚, median and range; n 17).”
BackgroundMethodInfluentialSelf-citationAnterior hypophysitis and hashimoto's disease in a young woman
Goudie, R. B., & Pinkerton, P. H. (1962) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700830241 · Cited by 342 · cited 1×
“Lymphocytic hypophysitis was first described in 1962 by Goudie and Pinkerton (197), and since then at least 130 cases have been described (256).”
BackgroundEvidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta
Petraglia, F., Sawchenko, P. E., Rivier, J., & Vale, W. (1987) · Nature · doi:10.1038/328717a0 · Cited by 337 · cited 1×
“(40) demonstrated that CRH modulates release of placental ACTH.”
BackgroundPhillips, D. I. W. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.757 · Cited by 337
The hypothalamic-pituitary-adrenal axis and the female reproductive system
MAGIAKOU, M. A., MASTORAKOS, G., WEBSTER, E., & CHROUSOS, G. P. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52128.x · Cited by 320 · cited 1×
“(41) and is identical to hypothalamic CRH in structure, immunoreactivity, bioactivity, and transcriptional sites (42).”
BackgroundGOLAND, R. S., WARDLAW, S. L., STARK, R. I., BROWN, L. S., & FRANTZ, A. G. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1199 · Cited by 281 · cited 1×
“These data suggest that the placenta is the source of elevated circulating CRH during gestation (44, 45, 57, 58).”
BackgroundFrim, D. M., Emanuel, R. L., Robinson, B. G., Smas, C. M., Adler, G. K., & Majzoub, J. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113585 · Cited by 267 · cited 1×
“Placental CRH mRNA was identified between wk 7 and 40 of gestation; it increased more than 20-fold in the 5 wk preceding parturition in parallel with rising plasma CRH concentrations (47, 48).”
BackgroundSASAKI, A., SHINKAWA, O., MARGIORIS, A. N., LIOTTA, A. S., SATO, S., MURAKAMI, O., GO, M., SHIMIZU, Y., HANEW, K., & YOSHINAGA, K. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-2-224 · Cited by 265 · cited 1×
“plasma cortisol concentrations increase severalfold with the onset of labor and delivery (3, 45, 143).”
BackgroundBeitins, I. Z., Bayard, F., Ances, I. G., Kowarski, A., & Migeon, C. J. (1973) · Pediatric Research · doi:10.1203/00006450-197305000-00004 · Cited by 259 · cited 2×
“While fetal cortisol concentrations are affected by 11β-HSD 2 enzyme activity, around three quarters of fetal cortisol originates from fetal adrenal gland production in term infants (21-23).”
BackgroundMethodWadhwa, P. D., Porto, M., Garite, T. J., Chicz-DeMet, A., & Sandman, C. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70219-4 · Cited by 251 · cited 2×
“Placental CRH may also be a marker of antepartum risk for preterm delivery (72).”
BackgroundGlucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programming
Seckl, J. R., Cleasby, M., & Nyirenda, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00984.x · Cited by 245
ALLOLIO, B., HOFFMANN, J., LINTON, E. A., WINKELMANN, W., KUSCHE, M., & SCHULTE, H. M. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00492.x · Cited by 244 · cited 9×
“serum progesterone and salivary cortisol during late pregnancy (17).”
BackgroundMethodResultInfluentialSerial Studies of Renal Function During Pregnancy and the Puerperium in Normal Women12
Sims, E. A. H., & Krantz, K. E. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103769 · Cited by 239 · cited 1×
“Pregnancy is associated with increases in glomerular filtration rate by 50% and an increase in filtered sodium load of 5,000–20,000 mEq (88, 89).”
BackgroundSteroids During Pregnancy and Possible Fetal Consequences
Bongiovanni, A. M., & McPadden, A. J. (1960) · Fertility and Sterility · doi:10.1016/s0015-0282(16)33723-2 · Cited by 236 · cited 1×
“In a large early report of women in 260 pregnancies treated with pharmacological doses of corticosteroids, there were eight stillbirths, 15 premature infants, and seven congenital abnormalities, two of which were cleft palate (312).”
BackgroundCorticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance
Makrigiannakis, A., Zoumakis, E., Kalantaridou, S., Coutifaris, C., Margioris, A. N., Coukos, G., Rice, K. C., Gravanis, A., & Chrousos, G. P. (2001) · Nature Immunology · doi:10.1038/ni719 · Cited by 227 · cited 1×
“Locally produced embryonic and endometrial CRH impedes rejection during implantation by inducing apoptosis in activated leukocytes carrying Fas ligand, thereby protecting the fetus from the maternal immune system (54, 70).”
BackgroundAron, D. C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1780 · Cited by 226
High prevalence and increasing incidence of Addison's disease in western Norway
Løvås, K., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.t01-1-01552.x · Cited by 222
Tordjman, K. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1301 · Cited by 219 · cited 1×
“There has been controversy as to whether the the LCT test offers additional sensitivity for detection of secondary AI (284, 292, 294, 295).”
BackgroundPossible placental origin of ACTH in normal human pregnancy
REES, L. H., BURKE, C. W., CHARD, T., EVANS, S. W., & LETCHWORTH, A. T. (1975) · Nature · doi:10.1038/254620b0 · Cited by 218 · cited 1×
“As discussed earlier, suppression of both plasma and urinary free cortisol by dexamethasone is blunted in pregnancy (4, 29).”
BackgroundIs the Prevalence of Addison's Disease Underestimated?
Laureti, S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1762 · Cited by 212
SCHULTE, H. M., WEISNER, D., & ALLOLIO, B. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00470.x · Cited by 199 · cited 5×
“Although two women experienced transient flushing, no other maternal or fetal side effects were noted (132).”
BackgroundInfluentialDiurnal Patterns and Regulation of Cortisol Secretion in Pregnancy*
NOLTEN, W. E., LINDHEIMER, M. D., RUECKERT, P. A., OPARIL, S., & EHRLICH, E. N. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-466 · Cited by 199 · cited 3×
“Other theories include an altered set point to the negative feedback mechanism controlling ACTH secretion (4, 5).”
BackgroundEPIDEMIOLOGICAL AND CLINICAL PICTURE OF ADDISON'S DISEASE
Stuart Mason, A., Meade, T. W., Lee, J. A. H., & Morris, J. N. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90948-3 · Cited by 195 · cited 1×
“(221) estimated one case of AI in pregnancy per 12,000 gestations.”
BackgroundLinton, E. A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.1.260 · Cited by 188 · cited 2×
“Circulating CRH-BP levels in early and midgestation are similar to nonpregnant levels, suggesting that, in contrast to CBG, CRH-BP is not stimulated by elevated estrogen levels in pregnancy (66).”
BackgroundKajantie, E., Dunkel, L., Turpeinen, U., Stenman, U.-H., Wood, P. J., Nuutila, M., & Andersson, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021378 · Cited by 188 · cited 3×
“Impaired activity of the enzyme and possible excessive fetal glucocorticoid exposure is observed in intrauterine growth retardation, and pre-eclampsia, which are commonly associated with preterm infants (22).”
BackgroundMethodElevated free cortisol index in pregnancy: Possible regulatory mechanisms
Nolten, W. E., & Rueckert, P. A. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90331-8 · Cited by 185 · cited 3×
“There also is a greater absolute rise in the unbound cortisol response, which increases as pregnancy advances (7).”
BackgroundSkinner, S. L., Lumbers, E. R., & SYMONDS, E. M. (1969) · PubMed · Cited by 185
ATSUSHI, S., ANTHONY, S. L., MARJORIE, M. L., ANDREW, N. M., TOSHIHIRO, S., & DOROTHY, T. K. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-4-812 · Cited by 184
Orth, D. N., & Mount, C. D. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91369-6 · Cited by 183 · cited 1×
“Human CRH-BP binds to human but not ovine CRH (65).”
BackgroundNIEMAN, L. K., CHROUSOS, G. P., OLDFIELD, E. H., AVGERINOS, P. C., CUTLER, G. B., & LORIAUX, D. L. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-862 · Cited by 174 · cited 1×
“In nonpregnant individuals with CD, the tumor corticotropes retain ACTH (and hence cortisol) responsiveness to CRH stimulation, whereas adrenal tumors and the majority of ectopic ACTH-producing tumors do not respond (192).”
BackgroundSelf-citationSerum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy
Demey-Ponsart, E., Foidart, J., Sulon, J., & Sodoyez, J. C. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90163-7 · Cited by 172 · cited 1×
“allel across gestation (11, 12), with plasma cortisol reported”
BackgroundJones, S. A., & Challis, J. R. G. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92422-4 · Cited by 171
Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy
Goland, R. S., Wardlaw, S. L., Blum, M., Tropper, P. J., & Stark, R. I. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80162-5 · Cited by 171 · cited 2×
“At the 35th week there is a sharp increase to a peak of 4000 pg/ml at 40 wk gestation (5, 52) (Fig.”
BackgroundBLOOD LEVELS OF 17-HYDROXYCORTICOSTEROIDS IN NORMAL PREGNANCY
GEMZELL, C. A. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-8-898 · Cited by 169
Tulchinsky, D., & Little, A. B. (1980) · Cited by 167
Tordjman, K., Jaffe, A., Trostanetsky, Y., Greenman, Y., Limor, R., & Stern, N. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00984.x · Cited by 167
CHEN, C.-L. C., CHANG, C.-C., KRIEGER, D. T., & BARDIN, C. W. (1986) · Endocrinology · doi:10.1210/endo-118-6-2382 · Cited by 163 · cited 2×
“CD 40 (33) Adrenal adenoma 56 (46) Carcinoma 12 (10) Carney’s complex 1 (0.”
BackgroundLado-Abeal, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3083 · Cited by 161
The maternal hypothalamic–pituitary–adrenal axis in the third trimester of human pregnancy
Magiakou, M., Mastorakos, G., Rabin, D., Margioris, A. N., Dubbert, B., Calogero, A. E., Tsigos, C., Munson, P. J., & Chrousos, G. P. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.683505.x · Cited by 159 · cited 8×
“There was no apparent circadian rhythm in plasma CRH despite preservation of circadian patterns of ACTH and cortisol (15).”
BackgroundMethodInfluentialCushing syndrome in pregnancy.
Buescher, M. A., McClamrock, H. D., & Adashi, E. Y. (1992) · PubMed · Cited by 154
Current Topic: The Uteroplacental Renin–Angiotensin System
Nielsen, A. H., Schauser, K., & Poulsen, K. (2000) · Placenta · doi:10.1053/plac.2000.0535 · Cited by 150 · cited 4×
“However other factors influence the plasma renin concentration including changes in salt intake, blood pressure, effects of progesterone, increased renin substrate concentration and the fetoplacental unit (87, 95, 104, 105).”
BackgroundInfluentialTabarin, A., Laurent, F., Catargi, B., Olivier‐Puel, F., Lescene, R., Berge, J., San Galli, F., Drouillard, J., Roger, P., & Guerin, J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00541.x · Cited by 148 · cited 1×
“In one series of nonpregnant individuals, the sensitivity of MRI for detection of CD decreased from 52% with contrast to 38% without (200).”
BackgroundCushing's syndrome and pregnancy
Aron, D. C., Schnall, A. M., & Sheeler, L. R. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90859-6 · Cited by 148
DÖRR, H. G., HELLER, A., VERSMOLD, H. T., SIPPELL, W. G., HERRMANN, M., BIDLINGMAIER, F., & KNORR, D. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-5-863 · Cited by 143 · cited 3×
“The aforementioned elevations in cortisol and its metabolites are consistent with a hypothesis that the maternal adrenals and the fetalplacental unit, in addition to estrogen-stimulated CBG elevations, all contribute to hypercortisolism in pregnancy (10, 18).”
BackgroundPoon, P. C., & Smith, J. F. (1996) · PubMed · Cited by 143
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease
Mayenknecht, J., Diederich, S., Bähr, V., Plöckinger, U., & Oelkers, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4831 · Cited by 142
Liotta, A. S., & Krieger, D. T. (1980) · Endocrinology · doi:10.1210/endo-106-5-1504 · Cited by 140 · cited 1×
“Short mRNA related to the gene encoding POMC was subsequently detected in human placenta (33) and trophoblastic cells synthesize POMC-derived peptides in vitro (34, 35).”
BackgroundThe Renin-Angiotensin-Aldosterone System in Preeclampsia
de Jong, C. L. D., Dekker, G., & Sibai, B. M. (1991) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30491-3 · Cited by 139
Hurel, S. J., Thompson, C. J., Watson, M. J., Harris, M. M., Baylis, P. H., & Kendall‐Taylor, P. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.555381.x · Cited by 138
Acute Asthma among Pregnant Women Presenting to the Emergency Department
Cydulka, R. K., Emerman, C. L., Schreiber, D. H., Molander, K., Woodruff, P. G., & Camargo, C. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812138 · Cited by 138 · cited 1×
“While chronic oral or high-dose corticosteroid use for asthma in pregnancy is associated with gestational diabetes, preterm labor and pre-eclampsia, there have been few reports of adrenal crisis in pregnancy (248).”
BackgroundReliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function
LINDHOLM, J., KEHLET, H., BLICHERT-TOFT, M., DINESEN, B., & RIISHEDE, J. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-2-272 · Cited by 134
Increased Exposure of Tissues to Cortisol in Late Pregnancy
Burke, C. W., & Roulet, F. (1970) · BMJ · doi:10.1136/bmj.1.5697.657 · Cited by 134 · cited 2×
“Plasma free cortisol elevations of two- to four-fold were reported across several studies, suggesting greater tissue exposure to glucocorticoids during pregnancy (4, 7, 16, 17).”
BackgroundMethodMaternal, but not fetal, administration of corticosteroids restricts fetal growth
Newnham, J. P., Evans, S. F., Godfrey, M., Huang, W., Ikegami, M., & Jobe, A. (1999) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199905/06)8:3<81::aid-mfm3>3.0.co;2-n · Cited by 134 · cited 1×
“The adverse effects of exogenous steroids and their contribution to fetal growth retardation, suppression of the fetal HPA axis and effects on neurological functioning, have previously been reviewed extensively in both animal models and in humans (241-245).”
BackgroundBakalov, V. K., Vanderhoof, V. H., Bondy, C. A., & Nelson, L. M. (2002) · Human Reproduction · doi:10.1093/humrep/17.8.2096 · Cited by 128 · cited 1×
“Positive adrenal antibodies predict the development of AI and may be elevated in other forms of organ-specific autoimmune disease (302).”
BackgroundQualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy
Cousins, L., Rigg, L. A., Hollingsworth, D. R., Meis, P. J., Franz Halberg, A., Brink, G. W., & Yen, S. S. C. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90309-5 · Cited by 125 · cited 4×
“Other theories include an altered set point to the negative feedback mechanism controlling ACTH secretion (4, 5).”
BackgroundInfluentialSCOTT, E. M., McGARRIGLE, H. H. G., & LACHELIN, G. C. L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-639 · Cited by 124 · cited 4×
“CD 40 (33) Adrenal adenoma 56 (46) Carcinoma 12 (10) Carney’s complex 1 (0.”
BackgroundResultInfluentialScreening for Adrenocortical Insufficiency With Cosyntropin (Synthetic ACTH)
Speckart, P. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.128.5.761 · Cited by 123 · cited 1×
“A plasma cortisol value of less than 18 μg/dl (497 nmol/l) after cosyntropin 250 μg was used for the diagnosis of AI in previous case reports (275, 288).”
MethodHELMER, O. M., GRIFFITH, R. S., Sanders, R. M., & Tilden, J. H. (1952) · Endocrinology · doi:10.1210/endo-51-5-421 · Cited by 122 · cited 11×
“The RAS comprises a cascade of events that proceeds from renin-mediated cleavage of the decapeptide angiotensinogen to angiotensin I, which is rate limiting.”
BackgroundInfluentialLymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases.
Ahmadi, J., Meyers, G. S., Segall, H. D., Sharma, O. P., & Hinton, D. R. (1995) · Radiology · doi:10.1148/radiology.195.1.7892490 · Cited by 121 · cited 1×
“As it has limited specificity for differentiation of lymphocytic hypophysitis from other pituitary masses, a biopsy may be required (but is rarely necessary) for a definitive diagnosis (256, 310).”
BackgroundPresence of Corticotropin in Human Placenta: Demonstration of in Vitro Synthesis
LIOTTA, A., OSATHANONDH, R., RYAN, K. J., & KRIEGER, D. T. (1977) · Endocrinology · doi:10.1210/endo-101-5-1552 · Cited by 118 · cited 1×
“Short mRNA related to the gene encoding POMC was subsequently detected in human placenta (33), and trophoblastic cells synthesize POMC-derived peptides in vitro (34, 35).”
BackgroundThe Renin — Angiotensin — Aldosterone System in Pre-Eclampsia
Brown, M. A., Wang, J., & Whitworth, J. A. (1997) · Clinical and Experimental Hypertension · doi:10.3109/10641969709083181 · Cited by 118 · cited 5×
“13 Significantly, aldosterone levels are reduced in pregnancy associated hypertension (96).”
BackgroundInfluentialFALORNI, A., LAURETI, S., NIKOSHKOV, A., PICCHIO, M. L., HALLENGREN, B., VANDEWALLE, C. L., GORUS, F. K., BELGIAN DIABETES REGISTRY, TORTOIOLI, C., LUTHMAN, H., et al. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1997.262-ce1153.x · Cited by 117
Management of Asthma during Pregnancy
Greenberger, P. A., & Patterson, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121406 · Cited by 115
Petraglia, F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1427 · Cited by 114
LINTON, E. A., BEHAN, D. P., SAPHIER, P. W., & LOWRY, P. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1574 · Cited by 114
PLASMA-17-HYDROXYCORTICOSTEROIDS IN PREGNANCY
Bayliss, R. I. S., Browne, J. C. M., Round, B. P., & Steinbeck, A. W. (1955) · The Lancet · doi:10.1016/s0140-6736(55)90002-7 · Cited by 113
Odagiri, E., Sherrell, B. J., Mount, C. D., Nicholson, W. E., & Orth, D. N. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.2027 · Cited by 108
Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature
Berwaerts, J., Verhelst, J., Mahler, C., & Abs, R. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167552 · Cited by 105 · cited 3×
“Ketoconazole has been used successfully without adverse event in three anecdotal reports of pregnancies (211–213), including in an individual who had discontinued contraception while using ketoconazole, 600-1000 mg, for CD (211).”
BackgroundMethodInfluentialThe Influence of Estrogen and Progesterone on Aldosterone Excretion*†
LAIDLAW, J. C., RUSE, J. L., & GORNALL, A. G. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-2-161 · Cited by 103 · cited 1×
“Plasma progesterone concentrations increase progressively throughout pregnancy to between 100 and 300 ng/ml in parallel with increases in plasma estradiol levels (87, 90).”
BackgroundFUNCTIONS OF THE RENIN‐ANGIOTENSIN SYSTEM DURING DEVELOPMENT
Lumbers, E. R. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb02057.x · Cited by 102
Pregnancy Associated with Diseases of the Adrenal Glands
Hunt, A. B., & McConahey, W. M. (1953) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)38611-2 · Cited by 102 · cited 3×
“Despite inadequate tumor definition using these modalities, several women had successful localization and surgery (148, 170).”
BackgroundMethodRole of stress peptides during human pregnancy and labour
Hillhouse, E. W., & Grammatopoulos, D. K. (2002) · Reproduction · doi:10.1530/rep.0.1240323 · Cited by 101 · cited 2×
“Plasma CRH levels rise exponentially by 1000-fold as gestation progresses (49), beginning around 8 wk gestation (50, 51).”
BackgroundThe effects of repeat doses of antenatal corticosteroids on maternal adrenal function
McKenna, D. S., Wittber, G. M., Nagaraja, H. N., & Samuels, P. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106755 · Cited by 100 · cited 4×
“greater than 19 g/dl (525 nmol/liter) (131, 281).”
BackgroundInfluentialIsolation and Characterization of a Corticotropin-Releasing Hormone-Like Peptide From Human Placenta
SASAKI, A., TEMPST, P., LIOTTA, A. S., MARGIORIS, A. N., HOOD, L. E., KENT, S. B. H., SATO, S., SHINKAWA, O., YOSHINAGA, K., & KRIEGER, D. T. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-768 · Cited by 100 · cited 1×
“(41) and is identical to hypothalamic CRH in structure, immunoreactivity, bioactivity, and transcriptional sites (42).”
BackgroundCUSHING'S SYNDROME IN PREGNANCY—TREATMENT WITH METYRAPONE
GORMLEY, M. J. J., HADDEN, D. R., KENNEDY, T. L., MONTGOMERY, D. A. D., MURNAGHAN, G. A., & SHERIDAN, B. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb00718.x · Cited by 99 · cited 1×
“The efficacy of the 8 mg dexamethasone suppression test for the differential diagnosis of ectopic ACTH secretion in pregnancy is unknown due to the limited number of reported cases (161, 163, 171, 178, 179, 189-191).”
BackgroundClose, C. F., Mann, M. C., Watts, J. F., & Taylor, K. G. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02380.x · Cited by 99 · cited 2×
“It is assumed that these outcomes could be prevented by reducing UFC excretion to the upper part of the range observed in normal pregnancy (186, 204, 205).”
BackgroundDynamic evaluation of adrenal hypofunction.
Nieman, L. K. (2003) · PubMed · Cited by 95
Self-citationCourtney, C. H., McAllister, A. S., McCance, D. R., Bell, P. M., Hadden, D. R., Leslie, H., Sheridan, B., & Atkinson, A. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01106.x · Cited by 95 · cited 9×
“Conversely, higher cutoff points for the diagnosis based on ITT criteria may result in a higher proportion of normal subjects misdiagnosed.”
BackgroundResultInfluentialSasaki, A., Shinkawa, O., & Yoshinaga, K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114390 · Cited by 93
Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy
Marinoni, E., Korebrits, C., Iorio, R. D., Cosmi, E. V., & Challis, J. R. G. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70490-9 · Cited by 93 · cited 1×
“In one study circulating values were not changed by administration of betamethasone, 12 mg (59), whereas others found increased CRH concentrations in maternal and fetal plasma and amniotic fluid after betamethasone (60).”
BackgroundDesoxycorticosterone in normal pregnancy
Nolten, W. E., Lindheimer, M. D., Oparil, S., & Ehrlich, E. N. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90777-9 · Cited by 93 · cited 2×
“(120) have speculated that placental progesterone might be converted to DOC by the fetal adrenals.”
BackgroundRapid ACTH Test with Plasma Aldosterone Levels: Improved Diagnostic Discrimination
DLUHY, R. G., HIMATHONGKAM, T., & GREENFIELD, M. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-6-693 · Cited by 90 · cited 1×
“14 nmol/liter) at 30 min after cosyntropin supports a diagnosis of primary AI in nonpregnant subjects (283, 303).”
BackgroundCope, O., & Raker, J. W. (1955) · New England Journal of Medicine · doi:10.1056/nejm195507282530401 · Cited by 90
Effect of administered mineralocorticoids or ACTH in pregnant women
Ehrlich, E. N., & Lindheimer, M. D. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106926 · Cited by 88 · cited 1×
“under tight physiological control (85, 116, 117).”
Pregnancy-induced Cushing's syndrome in multiple pregnancies
Wallace, C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.15 · Cited by 88 · cited 1×
“There is one report of fetal hypoadrenalism following metyrapone (151).”
BackgroundRenin-Aldosterone Relationships in Pregnancy-Induced Hypertension: An Alternative Viewpoint
Brown, M. A., Zammit, V. C., Mitar, D. A., & Whitworth, J. A. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.6.366 · Cited by 88 · cited 3×
“a disproportionate rise in plasma aldosterone concentrations compared with the magnitude of renin secretion suggesting a possible increase of some other unknown pregnancy associated factor that contributes to plasma aldosterone concentrations in pregnancy (97, 114).”
BackgroundResultKeleştimur, F. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03351067 · Cited by 86 · cited 1×
“Imaging of the adrenal glands can detect the large glands associated with tuberculous or fungal infection, bilateral metastases, hemorrhage, or infarction (274, 277, 305).”
BackgroundCushingʼs Syndrome in Pregnancy
PICKARD, J., JOCHEN, A. L., SADUR, C. N., & HOFELDT, F. D. (1990) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199002000-00002 · Cited by 84
Oparil, S., Ehrlich, E. N., & Lindheimer, M. D. (1975) · Clinical Science · doi:10.1042/cs0490139 · Cited by 84 · cited 1×
“However other factors influence the plasma renin concentration including changes in salt intake, blood pressure, effects of progesterone, increased renin substrate concentration and the fetoplacental unit (87, 95, 104, 105).”
BackgroundUrocortin Expression in Human Pituitary Gland and Pituitary Adenoma
Iino, K., Sasano, H., Oki, Y., Andoh, N., Shin, R.-W., Kitamoto, T., Totsune, K., Takahashi, K., Suzuki, H., Nagura, H., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4371 · Cited by 84 · cited 1×
“The pituitary is the site with the highest immunoreactive urocortin in man (78).”
BackgroundPetraglia, F. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1420 · Cited by 82 · cited 2×
“Urocortin has a stimulatory effect on ACTH release equimolar to CRH (81) and may maximize placental release of ACTH.”
BackgroundUrocortins in human reproduction
Florio, P., Vale, W., & Petraglia, F. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.026 · Cited by 82 · cited 4×
“Table 2 illustrates the putative effects of the urocortins and CRH described in a recent review (75).”
BackgroundInfluentialAsaba, K., Makino, S., & Hashimoto, K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00747-1 · Cited by 82 · cited 1×
“Urocortin stimulates increases in ACTH in rat pituitary cell cultures and in plasma with similar or greater potency than CRH (56, 76, 77).”
BackgroundNolten, W. E., Lindheimer, M. D., Oparil, S., & Ehrlich, E. N. (1978) · PubMed · Cited by 82
Plasma Deoxycorticosterone in Normal and Abnormal Human Pregnancy1
BROWN, R. D., STROTT, C. A., & LIDDLE, G. W. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-5-736 · Cited by 81
Myllykangas-Luosujärvi, R., Aho, K., & Isomäki, H. A. (1995) · PubMed · Cited by 80
Single-dose metyrapone test: review of a four-year experience
Spiger, M. J. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.135.5.698 · Cited by 80
Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report
Connell, J. M. C., Cordiner, J. W., Davies, D. L., Fräser, R., Frier, B. M., & McPHERSON, S. G. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb03037.x · Cited by 79 · cited 2×
“However, although metyrapone is effective, there is the potential for exacerbation of hypertension and progression to preeclampsia, which may limit its use (155, 178).”
BackgroundSuccessful treatment with ketoconazole of Cushing's syndrome in pregnancy
Amado, J. A., Pesquera, C., Gonzalez, E. M., Otero, M., Freijanes, J., & Alvarez, A. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.773.221 · Cited by 79
Diagnosis and management of Addison’s disease during pregnancy
Ambrosi, B., Barbetta, L., & Morricone, L. F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347034 · Cited by 78 · cited 7×
“Low plasma aldosterone in the setting of elevated PRA may have utility for assessment of the adequacy of mineralocorticoid replacement therapy, but this has not been formally validated in pregnancy.”
BackgroundInfluentialHigh risk pregnancies in hypopituitary women
Overton, C. E., Davis, C. J., West, C., Davies, M. C., & Conway, G. S. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1464 · Cited by 78 · cited 2×
“One single center series reported 18 patients with live births in 61%, miscarriage in 28%, midtrimester uterine death rate in 11%, and a high rate of fetal loss in twin pregnancy (258).”
BackgroundHána, V., Dokoupilová, M., Marek, J., & Plavka, R. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01055.x · Cited by 77
Trainer, P. J. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-36710 · Cited by 76
Aggelidou, E., Hillhouse, E. W., & Grammatopoulos, D. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052296399 · Cited by 75 · cited 1×
“Whereas the urocortins probably stimulate contractility of the myometrium, CRH acts in an inhibitory fashion via its effects on a nitric oxide synthase-dependent pathway (75, 84).”
BackgroundMaternal-Fetal ACTH Relationship in Man
ALLEN, J. P., COOK, D. M., KENDALL, J. W., & McGILVRA, R. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-2-230 · Cited by 75 · cited 2×
“Women in the third trimester treated with high-dose glucocorticoids (dexamethasone, 24 mg) before delivery exhibit suppressed ACTH levels within the first 24 h postpartum compared with untreated controls (137), but these effects are short lived (138).”
BackgroundPatrick, J., Challis, J. R. G., Natale, R., & Richardson, B. S. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90393-4 · Cited by 74 · cited 10×
“Exogenous human CRH, 1 g/kg, failed to increase plasma 780 Endocrine Reviews, October 2005, 26(6):775–799 Lindsay and Nieman • HPA Axis and Pregnancy”
BackgroundInfluentialMukherjee, J. J., Jacome de Castro, J., Kaltsas, G., Afshar, F., Grossman, A. B., Wass, J. A. H., & Besser, G. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2151035.x · Cited by 74 · cited 8×
“Conversely, higher cutoff points for the diagnosis based on ITT criteria may result in a higher proportion of normal subjects misdiagnosed.”
ResultInfluentialChallis, J., Sloboda, D., Matthews, S., Holloway, A., Alfaidy, N., Howe, D., Fraser, M., & Newnham, J. (2000) · Endocrine Research · doi:10.3109/07435800009048560 · Cited by 74 · cited 1×
“The adverse effects of exogenous steroids and their contribution to fetal growth retardation, suppression of the fetal HPA axis and effects on neurological functioning, have previously been reviewed extensively in both animal models and in humans (241-245).”
BackgroundKorebrits, C., Yu, D. H. T., Ramirez, M. M., Marinoni, E., Bocking, A. D., & Challis, J. R. G. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10158.x · Cited by 74 · cited 1×
“Figure 1 illustrates the normal physiological 3-fold rise in plasma cortisol observed during the 3rd trimester of normal pregnancy (3, 120, 131, 282).”
BackgroundThe uteroplacental renin-angiotensin system: a review
Hagemann, A., Nielsen, A. H., & Poulsen, K. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211289 · Cited by 74 · cited 1×
“Increased concentrations of renin are demonstrated within uterus, placenta and amniotic fluid (95, 98-101).”
BackgroundLeiba, S., Weinstein, R. S., Schindel, B., Lapidot, M., Stern, E., Levavi, H., Rusecki, Y., & ABRAMOVICI, A. (1989) · PubMed · Cited by 72
Madhappan, B., Kempuraj, D., Christodoulou, S., Tsapikidis, S., Boucher, W. S., Karagiannis, V., Athanassiou, A., & Theoharides, T. C. (2003) · Endocrinology · doi:10.1210/en.2003-0063 · Cited by 71 · cited 1×
“Plasma CRH levels rise exponentially by 1000-fold as gestation progresses (49), beginning around 8 wk gestation (50, 51).”
BackgroundCushing's Disease: The Surgical Experience in the Care of46Cases
Cope, O., & Raker, J. W. (1955) · New England Journal of Medicine · doi:10.1056/nejm195508042530502 · Cited by 70
Hypercortisolism and the Resistance to Dexamethasone Suppression during Gestation.
ODAGIRI, E., ISHIWATARI, N., ABE, Y., JIBIKI, K., ADACHI, T., DEMURA, R., DEMURA, H., & SHIZUME, K. (1988) · Endocrinologia Japonica · doi:10.1507/endocrj1954.35.685 · Cited by 70 · cited 5×
“: Endocrinol Jpn 35:685–690, 1988 (13).”
BackgroundInfluentialPlasma and Urinary Cortisol in Pregnancy and during Estrogen-Gestagen Treatment
Lindholm, J. (1973) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517309082426 · Cited by 68 · cited 2×
“This overlap of UFC values in pregnant women with and without CS suggests that only UFC values in the second and third trimester greater than three times the upper limit of normal can be taken to indicate CS (186).”
BackgroundKarteris, E., Hillhouse, E. W., & Grammatopoulos, D. (2004) · Endocrinology · doi:10.1210/en.2003-1210 · Cited by 66 · cited 1×
“Recent studies demonstrate that urocortin 2 interacts with myometrial CRH-R2s to stimulate myometrial contractility (83).”
BackgroundHigh molecular weight angiotensinogen levels in hypertensive pregnant women.
Tewksbury, D. A., & Dart, R. A. (1982) · Hypertension · doi:10.1161/01.hyp.4.5.729 · Cited by 66 · cited 1×
“lecular weight form (108), the exact role of which is unknown”
BackgroundThe effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone
Meulenberg, P. M. M., & Hofman, J. A. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90175-r · Cited by 66 · cited 2×
“allel across gestation (11, 12), with plasma cortisol reported”
BackgroundDeoxycorticosterone Production and Regulation in Man*
SCHAMBELAN, M., & BIGLIERI, E. G. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-4-695 · Cited by 65 · cited 1×
“In the third trimester, whereas total DOC levels are unchanged after ACTH stimulation, free DOC levels are elevated, possibly due to displacement of free DOC from CBG-binding sites (121, 123, 124).”
BackgroundOkamoto, E., Takagi, T., Makino, T., Sata, H., Iwata, I., Nishino, E., Mitsuda, N., Sugita, N., Otsuki, Y., & Tanizawa, O. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009289 · Cited by 64 · cited 2×
“Both CRH and ACTH normalize within 2 h from delivery whereas normalization of plasma cortisol levels is more protracted (58).”
BackgroundSmith, R. (1998) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(98)00023-0 · Cited by 64 · cited 1×
“Maternal CRH acts as a biological clock that determines the length of gestation (55, 71), and premature or accelerated activation of the placental CRH system may be associated with earlier onset of labor and delivery (72).”
BackgroundAntenatal corticosteroids: the good, the bad and the unknown
Newnham, J. P., Moss, T. J. M., Nitsos, I., & Sloboda, D. M. (2002) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200212000-00006 · Cited by 64 · cited 1×
“The adverse effects of exogenous steroids and their contribution to fetal growth retardation, suppression of the fetal HPA axis and effects on neurological functioning, have previously been reviewed extensively in both animal models and in humans (241-245).”
BackgroundCushing’s Syndrome and Pregnancy
Sheeler, L. R. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30088-4 · Cited by 64
SUCCESSFUL MANAGEMENT OF CUSHING'S DISEASE DURING PREGNANCY BY TRANSSPHENOIDAL ADENECTOMY
Casson, I. F., Davis, J. C., Jeffreys, R. V., Silas, J. H., WILLIAMS, J., & Belchetz, P. E. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01169.x · Cited by 62 · cited 3×
“Conversely, CD appears to be less common in pregnancy, with rates of 58–70% in the general population compared with 33% in 122 pregnant women (149, 159, 179).”
BackgroundResultCushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients.
Guilhaume, B., Raffin‐Sanson, M., BILLAUD, L., BERTAGNA, X. Y., Laudat, M. H., & LUTON, J. P. (1992) · PubMed · Cited by 60
Addison's disease and pregnancy
Brent, F. (1950) · The American Journal of Surgery · doi:10.1016/0002-9610(50)90329-1 · Cited by 60 · cited 2×
“adrenal crisis and mortality (45%) in 39 cases of AI in pregnancy prior to 1946 (224).”
BackgroundPeripartum hypopituitarism and lymphocytic hypophysitis
Patel, M. C., GUNERATNE, N., HAQ, N., WEST, T. E. T., Weetman, A. P., & CLAYTON, R. N. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a069103 · Cited by 60 · cited 1×
“Lymphocytic hypophysitis has considerable overlap in clinical presentation with Sheehan’s syndrome, and these two conditions are the primary differential diagnoses for postpartum hypopituitarism (255).”
BackgroundWEINBERGER, M. H., KRAMER, N. J., GRIM, C. E., & PETERSEN, L. P. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-1-69 · Cited by 59 · cited 1×
“pregnancy, in keeping with an increased sodium requirement for homeostasis (106).”
BackgroundIdentification of renin and renin messenger RNA sequence in rat ovary and uterus
Kim, S.-J., Shinjo, M., Fukamizu, A., Miyazaki, H., Usuki, S., & Murakami, K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90466-9 · Cited by 59 · cited 1×
“The ovary produces renin and prorenin (102, 103).”
BackgroundCUSHING'S SYNDROME IN PREGNANCY: THE TIMING OF DEFINITIVE TREATMENT
Bevan, J. S., Gough, M., Gillmer, M. D. G., & Burke, C. W. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01148.x · Cited by 59 · cited 1×
“tions, maternal cardiac failure, and death (154, 156, 175, 176) (Table 3).”
Ammari, F., Issa, B. G., Millward, E., & Scanlon, M. F. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.712533.x · Cited by 58 · cited 8×
“Conversely, higher cutoff points for the diagnosis based on ITT criteria may result in a higher proportion of normal subjects misdiagnosed.”
ResultInfluentialUrocortin and Corticotropin-Releasing Factor Receptor Expression in Normal Cycling Human Ovaries1
Muramatsu, Y., Sugino, N., Suzuki, T., Totsune, K., Takahashi, K., Tashiro, A., Hongo, M., Oki, Y., & Sasano, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7299 · Cited by 57 · cited 1×
“Urocortin 1 causes relaxation of placental vasculature; it stimulates prostaglandin E2 release in vitro (82) and may thus enhance prostaglandin release in vivo.”
BackgroundCushing's disease treated by trans-sphenoidal selective adenomectomy in mid-pregnancy
Mellor, A., Harvey, R., Pobereskin, L. H., & Sneyd, J. R. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/80.6.850 · Cited by 57 · cited 5×
“Approximately 20% underwent transsphenoidal surgery (164).”
BackgroundResultInfluentialBlumenfeld, Z., & Jaffe, R. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112563 · Cited by 56 · cited 1×
“by glucocorticoids, in contrast to negative feedback effects of cortisol on hypothalamic CRH (61, 62).”
BackgroundRubin, P. C. (1990) · PubMed · Cited by 56
FINKENSTEDT, G., Gasser, R. W., Höfle, G., Lhotta, K., Kölle, D., Gschwendtner, A., & Janetschek, G. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343608 · Cited by 55 · cited 2×
“Magnetic resonance imaging (MRI) and computed tomography (CT) have been used effectively, although the former is preferred during pregnancy due to the risk of ionizing radiation (153, 180, 198).”
BackgroundMethodA Case of ACTH-Producing Pheochromocytoma Associated with Pregnancy
Oh, H. C., Koh, J., Kim, M., Park, J. Y., Shong, Y. K., Lee, K., Kim, G. S., Hong, S. J., Koo, H. L., & Kim, W. B. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.739 · Cited by 53 · cited 3×
“Ectopic ACTH secretion has been reported to cause CS in four patients, two of whom had a diagnosis of pheochromocytoma (174, 177).”
BackgroundCushing's disease and pregnancy: Report of six cases
Chico, A. I., Manzanares, J. M., Halperín, I., de Osaba, M. J. M., Adelantado, J., & Webb, S. M. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(95)02258-9 · Cited by 53 · cited 1×
“A high proportion, either presenting late in pregnancy or before modern management, was left untreated (209, 210).”
BackgroundSUDA, T., IWASHITA, M., USHIYAMA, T., TOZAWA, F., SUMITOMO, T., NAKAGAMI, Y., DEMURA, H., & SHIZUME, K. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-38 · Cited by 52 · cited 17×
“The normal gestational changes in the HPA axis alter these parameters and complicate the screening process for CS (3, 13, 133) (Figure 1).”
BackgroundResultInfluentialSodium‐renin‐aldosterone relations in normal and hypertensive pregnancy
Brown, M. A., Nicholson, E., & Gallery, E. D. M. (1988) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06812.x · Cited by 52 · cited 1×
“However other factors influence the plasma renin concentration including changes in salt intake, blood pressure, effects of progesterone, increased renin substrate concentration and the fetoplacental unit (87, 95, 104, 105).”
Background(1995) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a069058 · Cited by 52
Pinette, M. G., Pan, Y., Oppenheim, D. S., Pinette, S. G., & Blackstone, J. A. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90303-4 · Cited by 51 · cited 8×
“For others, IPSS may be warranted.”
BackgroundInfluentialDiagnosis and selective cure of Cushing's disease during pregnancy by transsphenoidal surgery
Ross, R., Chew, S., Perry, L., Erskine, K., Medbak, S., & Afshar, F. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320722 · Cited by 51 · cited 3×
“An elevated midnight or evening plasma cortisol has helped to confirm hypercortisolism in some pregnant women (153, 161, 164, 179).”
BackgroundResultAddison'S Disease And Pregnancy
Albert, E., Dalaker, K., Jorde, R., & Berge, L. N. (1989) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016348909009909 · Cited by 51
Okawa, T., Asano, K., Hashimoto, T., Fujimori, K., Yanagida, K., & Sato, A. (2002) · American Journal of Perinatology · doi:10.1055/s-2002-20170 · Cited by 50
Desoxycorticosterone in normal pregnancy
Nolten, W. E., Lindheimer, M. D., Oparil, S., RUECKERT, P. A., & Ehrlich, E. N. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90012-7 · Cited by 49
Mukherjee, K., & Swyer, G. I. M. (1972) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1972.tb14192.x · Cited by 49 · cited 7×
“Compared with healthy non-gravid women, basal plasma ACTH levels in pregnancy have been varyingly reported as low (3, 14) or high (37) using RIA.”
BackgroundMethodInfluentialChaiamnuay, S., Moster, M. L., Katz, M. R., & Kim, Y. N. (2003) · Pituitary · doi:10.1023/b:pitu.0000004802.47010.00 · Cited by 49 · cited 1×
“Pituitary MRI without gadolinium administration should be considered early in the evaluation of secondary AI to exclude a pituitary macroadenoma or space-occupying lesion (279, 308, 309).”
BackgroundQuinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49 · cited 2×
“While fetal cortisol concentrations are affected by 11β-HSD 2 enzyme activity, around three quarters of fetal cortisol originates from fetal adrenal gland production in term infants (21-23).”
BackgroundMethodOvarian Prorenin-Renin-Angiotensin System
Itskovitz, J., & Sealey, J. E. (1987) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198709000-00003 · Cited by 48 · cited 1×
“The ovary produces renin and prorenin (102, 103).”
BackgroundUrocortin and Corticotropin-Releasing Factor Receptor Expression in Normal Cycling Human Ovaries
Muramatsu, Y. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1362 · Cited by 48
Localization and Characterization of Urocortin during Human Pregnancy
Clifton, V. L., Qing, G., Murphy, V. E., Schwartz, J., Madsen, G., & Smith, R. (2000) · Placenta · doi:10.1053/plac.2000.0570 · Cited by 47 · cited 1×
“However, plasma urocortin 1 levels do not change through gestation until labor, when levels increase (79, 80).”
BackgroundThe effects of pregnancy on adrenal steroid metabolism.
Jd, M., & Mills, I. H. (1958) · PubMed · Cited by 46
Placental Corticotropin‐Releasing Factor An Update
Fadalti, M., Pezzani, I., Cobellis, L., Springolo, F., PETROVEC, M. M., Ambrosini, G., dos Reis, F. M., & Petraglia, F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06219.x · Cited by 44 · cited 1×
“These data suggest that the placenta is the source of elevated circulating CRH during gestation (44, 45, 57, 58).”
BackgroundNakai, Y., Nakao, K., Oki, S., Imura, H., & Li, C. H. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90194-7 · Cited by 44
Schmidt's syndrome presenting with intrauterine growth retardation and postpartum addisonian crisis
Drucker, D. J., Shumak, S. L., & Ángel, A. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90206-0 · Cited by 44 · cited 5×
“Consequently, the need for treatment of AI may be recognized only in the immediate postpartum period (236).”
BackgroundInfluentialAdrenal Suppression Induced by Betamethasone in Women at Risk for Premature Delivery
Helal, K., GORDON, M. C., LIGHTNER, C. R., & BARTH, W. H. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00885-1 · Cited by 43 · cited 1×
“standard short-term doses of betamethasone for pre-term delivery (131, 250).”
BackgroundSehringer, B., Hp, Z., Simon, M., Ziegler, R., Nöthling, C., & Schaefer, W. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320339 · Cited by 43 · cited 6×
“Recent studies demonstrate that urocortin 2 interacts with myometrial CRH-R2s to stimulate myometrial contractility (83).”
BackgroundInfluentialManagement of Cushing's syndrome secondary to adrenal adenoma during pregnancy.
Pricolo, V. E., Monchik, J. M., Prinz, R. A., DeJong, S., Chadwick, D. A., & Lamberton, R. P. (1990) · PubMed · Cited by 43
Roles of Reproductive Corticotropin‐Releasing Hormone
KALANTARIDOU, S. N., MAKRIGIANNAKIS, A., MASTORAKOS, G., & CHROUSOS, G. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.015 · Cited by 40 · cited 3×
“Kalantaridou et al: Ann NY Acad Sci 997:129–135, 2003 (53).”
BackgroundInfluentialOchędalski, T., Żylińska, K., LAUDAŃSKI, T., & Lachowicz, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440117 · Cited by 40 · cited 3×
“those requiring induction, consistent with a central role in the onset of parturition (73, 74).”
BackgroundSheehan, H. L. (1961) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576105400111 · Cited by 40 · cited 1×
“Although it is the most widely cited cause of hypopituitarism in association with pregnancy, this condition has become less common with improved obstetric care (253, 254).”
BackgroundSodium and mineralocorticoids in normal pregnancy
Nolten, W. E., & Ehrlich, E. N. (1980) · Kidney International · doi:10.1038/ki.1980.125 · Cited by 39 · cited 2×
“Plasma aldosterone concentrations are elevated 5 to 7-fold during the first trimester (18) and continue to increase until the 38 week of gestation when 10 to 20-fold elevations are reached (18, 86, 113).”
BackgroundQuinkler, M., Meyer, B., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030092 · Cited by 39 · cited 1×
“contributes to reduced systemic vascular resistance, causing smooth muscle relaxation (91, 92).”
BackgroundPrebtani, A. P. H., Donat, D., & Ezzat, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02242-x · Cited by 39 · cited 1×
“reports of pregnancies (211-213), including in an individual who had discontinued contraception”
EGERMAN, R., PIERCEIV, W., ANDERSEN, R., UMSTOT, E., CARR, T., & SIBAI, B. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(96)00446-2 · Cited by 38 · cited 1×
“In another series, the bioavailability of an 8-mg oral dose was similar to 6-mg im dosing (142).”
BackgroundFast MRI and its application in obstetrics
Levine, D., & Edelman, R. R. (1997) · Abdominal Imaging · doi:10.1007/s002619900268 · Cited by 37 · cited 1×
“Although MRI provides excellent soft tissue enhancement and has improved resolution compared with ultrasound (306, 307), during the differential diagnosis we recommend deferment of adrenal imaging until the postpartum period, provided that the patient is clinically stable (277).”
BackgroundBrown, M. A., Pipkin, F. B., & SYMONDS, E. M. (1988) · Journal of Hypertension · doi:10.1097/00004872-198806000-00005 · Cited by 37 · cited 1×
“plasma aldosterone concentrations in pregnancy (97, 114).”
Cushing’s Syndrome in Pregnancy Secondary to Adrenal Adenoma
Lo, K. W., & Lau, T. K. (1998) · Gynecologic and Obstetric Investigation · doi:10.1159/000009958 · Cited by 37
The Dexamethasone Suppression Test in the Puerperium
Greenwood, J., & Parker, G. (1984) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048678409161303 · Cited by 36 · cited 1×
“In the immediate postpartum period 82% of women in one series did not have normal cortisol suppression after 1 mg dexamethasone (146).”
BackgroundGlynn, B. P., Wolton, A., Rodríguez-Liñares, B., Phaneuf, S., & Linton, E. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70391-6 · Cited by 36 · cited 1×
“However, plasma urocortin 1 levels do not change through gestation until labor, when levels increase (79, 80).”
BackgroundThe pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy
Elliott, C. L., Read, G. F., & Wallace, E. M. (1996) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349609047089 · Cited by 35 · cited 1×
“In one series, bioavailability via the oral route was 72% of the im route (141).”
Background
Research works printed but not linked: 2
- Iwase, 1992, Reproductive and developmental toxicity studies of hCRH [corticotrophin releasing hormone (human)] (II): study on intravenous administration of hCRH during the period of organogenesis in rats, Yakuri to Chiryo, 20, 89
- Shaw, 2002, Cushing’s syndrome during pregnancy: curative adrenalectomy at 31 weeks gestation., Eur J Obstet Gynecol Reprod Biol, 15, 189, 10.1016/s0301-2115(02)00148-3 · DOI
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“Furthermore, suppression of serum and urinary cortisol by dexamethasone is blunted in pregnancy (105).”
BackgroundSelf-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Self-citationInfluence of Maternal Obesity on the Long-Term Health of Offspring
Godfrey, K. M., Reynolds, R. M., Prescott, S. L., Nyirenda, M., Jaddoe, V. W. V., Eriksson, J. G., & Broekman, B. F. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30107-3 · Cited by 1,059
The effects of sex and hormonal status on the physiological response to acute psychosocial stress
Kajantie, E., & Phillips, D. I. W. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.07.002 · Cited by 1,035
“During pregnancy, there are major changes in the physiology of the HPAA (Mastorakos and Ilias, 2003; Lindsay and Nieman, 2005; de Weerth and Buitelaar, 2005).”
Background
Metadata
- Authors
- Lindsay, J. R., & Nieman, L. K.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Nieman, Lynnette K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-10-01
- Volume
- 26
- Issue
- 6
- Pages
- 775-799
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2157312224
- Semantic Scholar
- 3acc03fac02b571c837b2ab90f9ef89e94cf0136
- Cited by
- 449
- References
- 342
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 22 · 2023: 22 · 2022: 30 · 2021: 22 · 2020: 21 · 2019: 22 · 2018: 24 · 2017: 22 · 2016: 26 · 2015: 29 · 2014: 21 · 2013: 17 · 2012: 35
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- hypothalamic-pituitary-adrenal axis, pregnancy, Cushing's syndrome, ACTH, cortisol, corticotropin-releasing factor, pituitary desensitization, Cushing's disease, adrenal insufficiency, inferior petrosal sinus sampling, fetal morbidity, postpartum period, labor management
- MeSH terms
- Adrenal Gland Diseases, Adrenal Insufficiency, Adrenal Glands, Cushing Syndrome, Female, Fetal Death, Humans, Hypothalamo-Hypophyseal System, Maternal Mortality, Pregnancy, Pregnancy Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.